Analytical Data
-
Gene name
apM1
- Application
-
Alternative Names
apM1
-
Species
Cat
-
Source
E. coli
-
Tag
Tag Free
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A4PB30
-
Expression Region
18-244aa
-
Molecular Weight
24.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on the apM1 recombinant protein has emerged from the growing interest in understanding the biological functions and applications of various proteins in biotechnology and medicine. apM1, a protein associated with the regulation of metabolic processes and immune responses, has garnered attention due to its potential roles in both basic research and therapeutic development. The increasing prevalence of metabolic disorders and immune-related diseases has prompted scientists to explore the molecular mechanisms involving apM1 and its interactions within cellular networks. Recombinant technology allows for the production of large quantities of apM1, enabling detailed studies of its structure, function, and potential applications. Recent advancements in protein engineering and expression systems have facilitated the generation of modified apM1 variants with enhanced properties, paving the way for innovative strategies in drug design, vaccine development, and personalized medicine. Additionally, understanding the functional dynamics of apM1 can lead to novel therapeutic approaches aimed at restoring metabolic balance and improving immune function, thereby addressing significant health challenges. As research continues to unfold, the comprehensive characterization of apM1 recombinant protein holds great promise for contributing to both scientific knowledge and practical applications in health and disease management.
